Sign Up
Stories
FDA Breakthrough Device Designation for Supira Medical and Magenta Medical
Share
Cordis and Boston Scientific: Advancemen...
Innovative Cardiac Support Devices Recei...
AI-Powered Raspberry Pi Stethoscope Inno...
Advanced Technology Saves Patient's Life
Attune Medical's Growth in Esophageal Te...
Overview
API
Supira Medical and Magenta Medical have received FDA breakthrough device designation for their percutaneous ventricular assist devices. PercAssist has announced the first patient treated in its EUREKA study of the PSCA System for hemodynamic support in chronic heart failure.
Ask a question
How do Supira Medical's Supira System and Magenta Medical's Elevate System differ?
What are the next steps for Supira Medical and Magenta Medical after receiving FDA breakthrough device designation?
What are the potential benefits of PercAssist's PSCA System for chronic heart failure patients?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Jun 2023
Jul 2023
Aug 2023
Sep 2023
Oct 2023
Coverage
stree